Hepcidin promotes osteogenic differentiation through the bone morphogenetic protein 2/small mothers against decapentaplegic and mitogen-activated protein kinase/P38 signaling pathways in mesenchymal stem cells
Authors:
Open Access
- 24 October 2014
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 11 (1) , 143-150
Abstract
The ability of mesenchymal stem cells (MSCs) to differentiate into osteogenic lineages requires management for their future use in treating bone destruction and osteoporosis. Hepcidin is closely associated with bone metabolism, however, it remains to be elucidated whether hepcidin affects osteogenic differentiation in MSCs. The present study demonstrated that hepcidin enhanced osteoblastic differentiation and mineralization, which was manifested by an upregulation in the differentiation markers alkaline phosphatase and osteogenic genes. Furthermore, the expression levels of bone morphogenetic proteins and small mothers against decapentaplegic homologs were concomitantly increased following hepcidin treatment. In addition, the p38 mitogen-activated protein kinase may be an upstream kinase for osteoblastic differentiation. Thus, hepcidin may be important in the osteogenic differentiation of MSCs and may be considered as a target in the development of therapies for pathological bone loss.Keywords
This publication has 34 references indexed in Scilit:
- Interpretation of protein quantitation using the Bradford assay: Comparison with two calculation modelsAnalytical Biochemistry, 2013
- Metabolomic Profiles Delineate Signature Metabolic Shifts during Estrogen Deficiency-Induced Bone Loss in Rat by GC-TOF/MSPLOS ONE, 2013
- Nectandrin A Enhances the BMP-Induced Osteoblastic Differentiation and Mineralization by Activation of p38 MAPK-Smad Signaling PathwayThe Korean Journal of Physiology & Pharmacology, 2013
- Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammationAmerican Journal of Hematology, 2011
- Osteoporosis: now and the futureThe Lancet, 2011
- Rapamycin Promotes the Osteoblastic Differentiation of Human Embryonic Stem Cells by Blocking the mTOR Pathway and Stimulating the BMP/Smad PathwayStem Cells and Development, 2010
- Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4Blood, 2007
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingStem Cells, 2007
- Iron loading: a risk factor for osteoporosisBioMetals, 2006
- Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohortInternational Journal of Cancer, 2004